Earnings Call · Q2 FY2022·2022-08-10

Q2 22EPS +12.50%·Rev n/aQ1 22EPS -12.50%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS +7.14%·Rev n/a⚠ consensus missing

ADMA BIOLOGICS, INC. ADMA

Skyler Bloom — Investor Relations or Corporate Communications (inferred from context)

Adam Grossman — President and Chief Executive Officer

Brian Lenz — Executive Vice President, Chief Financial Officer

+5.2%1d on move date+5.2% vs SPY3d+13.7%5d+15.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADMA calls or request research access.

More ADMA calls Browse calls Request research access